.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Healthtrust
UBS
Merck
US Army
Covington
Chinese Patent Office
Daiichi Sankyo
Harvard Business School

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074477

« Back to Dashboard

NDA 074477 describes CAPTOPRIL, which is a drug marketed by Apotex, Apothecon, Boscogen, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan Pharms Inc, Par Pharm, Prinston Inc, Purepac Pharm, Sandoz, Teva, Vintage Pharms Llc, Watson Labs, Wockhardt, Ivax Sub Teva Pharms, and Mylan, and is included in twenty-eight NDAs. It is available from twenty-nine suppliers. Additional details are available on the CAPTOPRIL profile page.

The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

Summary for 074477

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074477

Suppliers and Packaging for NDA: 074477

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPTOPRIL captopril TABLET;ORAL 074477 ANDA SANDOZ INC. 0781-8052 0781-8052-10 1000 TABLET in 1 BOTTLE (0781-8052-10)
CAPTOPRIL captopril TABLET;ORAL 074477 ANDA SANDOZ INC. 0781-8052 0781-8052-01 100 TABLET in 1 BOTTLE (0781-8052-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Feb 13, 1996TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Merck
QuintilesIMS
Healthtrust
Federal Trade Commission
Dow
Queensland Health
Harvard Business School
Daiichi Sankyo
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot